Regeneron Pharmaceuticals, Inc. REGN reported fourth-quarter 2024 earnings per share (EPS) of $12.07, which beat the Zacks Consensus Estimate of $11.62. The company recorded an EPS of $11.86 in the ...

Vabysmo pre-filled syringe now also approved ... so there were more costs coming from other units into SG&A. Diabetes Care is one element that we integrated, just to mention example here, that's ...

Roche will continue a careful approach to high-priced deals, putting science at the center of its business development ...

helped by lower costs and growth from drugs such as eye treatment Vabysmo and cancer drug Phesgo. Roche sees high single-digit core profit growth in 2025 A Washington jury on Tuesday ordered Bayer ...

These findings underline Libtayo’s “potential to also transform the treatment of high-risk resectable cutaneous squamous cell carcinoma with adjuvant treatment,” Israel Low, clinical development unit ...

KYIV, Feb 5 (Reuters) - Ukraine's military will create robotic vehicle units to deploy at the front, the defence minister said on Wednesday, as Kyiv and Moscow vie to gain a technological ...

After repeatedly wowing investors, Roche’s star eye med Vabysmo collected more than $4 billion in sales during its third year on the market. Still, questions continue to swirl about an evolving ...

The fight for dominance between Regeneron and Bayer’s big blockbuster eye drug Eylea and Roche’s rival Vabysmo is playing out in arenas beyond just prescription counts and sales numbers.

Hoffmann-La Roche Limited (Roche Canada) announced that Health Canada has authorized Vabysmo (faricimab injection) for use in a 6.0 mg single-use pre-filled syringe (PFS) for use in the treatment of ...

Supply for Vabysmo PFS will become available to Canadian ophthalmologists and their patients in the coming months. Roche Canada is committed to continuing to work with the provincial and ...

MISSISSAUGA, ON, Jan. 20, 2025 /CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce today that Health Canada has authorized Vabysmo® (faricimab injection) for use in a 6.0 mg ...